دورية أكاديمية
Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study
| العنوان: | Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study |
|---|---|
| المؤلفون: | Sun, Yongchang, Molins, Eduard, Daoud, Sami Z., Trivedi, Roopa, Stewart, Catherine, Lamarca, Rosa, Bharali, Pranob, Garcia-Gil, Esther |
| المساهمون: | AstraZeneca plc |
| المصدر: | Respiratory Medicine ; volume 218, page 107393 ; ISSN 0954-6111 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Pulmonary and Respiratory Medicine |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.rmed.2023.107393 |
| الإتاحة: | https://doi.org/10.1016/j.rmed.2023.107393Test https://api.elsevier.com/content/article/PII:S0954611123002810?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0954611123002810?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.D6B5A890 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.rmed.2023.107393 |
|---|